Selected catalogue fields; this score does not confirm eligibility or application readiness.Application evidence · 1 of 7 selected topics
Deadline
Not published
Funding
Published by official source
International eligibility
Historical information only — confirm current terms
Registration
Not published
Language
Not published
Visa / work authorisation
Historical information only — confirm current terms
Required documents
Not published
Faculty documentation: 2 individual profile sources linked. Photos and roster sources are assessed separately.
The count covers the topics above. Clinical privileges and your own eligibility require separate confirmation with the host.
DECISION SUMMARY
Key facts at a glance
Eligibility
Unclear — confirm with host
Funding / fees
Annual salary PGY-6 equivalent plus benefits (University of Utah GME 2026-2027 level-6 stipend: $91,863).Published by official source. Financial support may cover expenses; it does not establish employment or a salary.
Deadline
31 December (annual date; the programme page gives no year)
Duration
One year (August 1 – July 31)
Hands-on
Unclear — confirm privileges
Clinical exposureExtensive tertiary/quaternary surgical exposure to the complete array of benign and malignant musculoskeletal neoplastic and pseudoneoplastic conditions in patients of all ages and anatomic locations, with broad paediatric and adult exposure. Weekly schedule spans adult and paediatric sarcoma clinics, tumour boards (which fellows help lead) and surgery at University of Utah Health, Huntsman Cancer Institute and Primary Children's Hospital.
Participation levelClinical participation and hands-on restrictions must be confirmed directly with the host.
INTERNATIONAL APPLICANT CHECK
Can an international surgeon apply?
?Historical information only — confirm current terms
International applicants
Not addressed on the programme pages. An older (review date Jan 2011) University of Utah GME policy requires international medical graduates to hold an ECFMG certificate.
?Confirm directly with host
Clinical role
Clinical or combined training pathway; exact duties remain appointment-specific. Hands-on participation and operative restrictions are not explicitly published.
—Not published
Medical registration
Not published on the programme pages.
—Not published
Language
Not published in the reviewed University of Utah Sarcoma Fellowship programme page, application page and department home page (15 October 2026): no English-language test, minimum score or other language requirement is stated. Confirm any language requirement with the programme.
?Historical information only — confirm current terms
Visa or work authorisation
Not published on the programme pages. A University of Utah GME policy document (GME 15.1, review date Jan 2011) describes ECFMG J-1 sponsorship only for ACGME-accredited programmes; this fellowship is not ACGME accredited, so applicability is unclear (historical institutional information only).
DATA QUALITY & AVAILABILITYField-by-field evidence and review datesChecked 2026-10-15 · Next scheduled editorial review: 2027-04-13
✓ programme title✓ institution / department✓ city and country✓ programme classification✓ subspecialty✓ duration✓ positions✓ commencement / intake✓ funding✓ benefits✓ application process✓ application portal✓ official contact✓ faculty✓ verified faculty photograph✓ verified institution logo✓ official source✓ institutional source✓ accreditation / organisation source✓ verification date— Current availability unconfirmed · current availability unconfirmed— accommodation / relocation · not published by the cited official source— eligibility · not published by the cited official source— international eligibility · historical evidence only— Language requirement not published · not published by the cited official source— Registration information not published · not published by the cited official source— visa / work authorisation · historical evidence only— Current deadline not yet published · not published by the cited official source— required documents · not published by the cited official source
APPLICATION TIMELINE & CONTACT
Plan the application
Application deadline31 December (annual date; the programme page gives no year)
Commencing dateAugust 1
Application route / cycle2028 fellowship intake (training begins July/August 2028) via the 2027 SF Match Orthopaedic Fellowship Match: applicant registration opened 3 August 2026; the CAS target date (2 September 2026) has passed and SF Match states it is a suggested date, not a deadline; rank lists are due 6 April 2027 (12:00 noon PT) and Match Results are released 13 April 2027. Musculoskeletal Oncology (MSTS) timetable: interview period 17 December 2026 – March 2027. Utah's application page states 'Deadline: Generally by December 31st' (no year) with SF Match, interview dates left blank and a PGY-6-equivalent salary; read as 31 December 2026 for the 2027 Match cycle.
Not published on the programme pages (no stated residency, board or licensure criteria)
Application documents
Not published
Not itemised on the programme page (submitted via SF Match)
PROGRAM OVERVIEW
What this program offers
One-year sarcoma fellowship offering intensive tertiary/quaternary orthopaedic oncology surgery across adult and paediatric patients, with fellows co-leading the multidisciplinary sarcoma tumour board and completing at least one submitted peer-reviewed manuscript.
BENEFITS & SUPPORT
Published benefits and support
Programme supports attendance at one national meeting per year. Institutional GME trainee benefits (2026-27): 15 working days paid vacation plus 5 days personal/professional development, 5 days sick leave, health insurance (~90% hospital-paid), dental, group term life, disability insurance, 401(a) retirement contribution (3%), malpractice cover for in-state training activities.
HOST INSTITUTION
About University of Utah Spencer Fox Eccles School of Medicine, Department of Orthopaedics (University of Utah Health / Huntsman Cancer Institute)
The University of Utah Department of Orthopaedics runs its sarcoma service with Huntsman Cancer Institute and Primary Children's Hospital in Salt Lake City.
Fellowship Director; Professor, Department of Orthopaedics; Adjunct Professor of Oncological SciencesIndividual profile linkedPhoto source linked
Position / status
Professor of Orthopaedics, University of Utah; Division Chief, Sarcoma; Leader, Huntsman Cancer Institute Sarcoma Disease Center
Affiliation
University of Utah Health / Huntsman Cancer Institute
Clinical focus
Paediatric and adult sarcoma, bone sarcoma, desmoid tumours; laboratory research on fusion oncogene-associated sarcomas.
Qualifications
MD, Johns Hopkins University; orthopaedic surgery residency, University of Iowa; musculoskeletal oncology fellowship, Mount Sinai Hospital; American Board of Orthopaedic Surgery certification listed.
Kevin B. Jones, MD, is professor in the Department of Orthopaedics at the University of Utah, adjunct professor of oncological sciences, Division Chief of Sarcoma in the department, and leader of the Huntsman Cancer Institute Sarcoma Disease Center. His University of Utah Health profile lists clinical work in paediatric and adult sarcoma, bone sarcoma and desmoid tumours, and a research laboratory studying fusion oncogene-associated sarcomas with mouse genetic models. He received his MD from Johns Hopkins University, trained in orthopaedic surgery at the University of Iowa Hospitals and Clinics, and completed a musculoskeletal oncology fellowship at Mount Sinai Hospital. The intake, supervision and current availability of the linked fellowship must be confirmed with the host.
Assistant Professor, OrthopaedicsIndividual profile linkedPhoto source linked
Position / status
Assistant Professor, Orthopaedics, University of Utah; Musculoskeletal Oncology and Sarcoma Center, Huntsman Cancer Institute
Affiliation
University of Utah Health / Huntsman Cancer Institute
Clinical focus
Soft tissue and bone sarcoma surgery, paediatric sarcoma, musculoskeletal oncology.
Qualifications
MD, University of South Florida; MS, Duke University; orthopaedic surgery residency, University of South Florida; sarcoma surgery fellowship, University of Utah; American Board of Orthopaedic Surgery certification listed.
John S. Groundland, MD, MS, is an assistant professor in the Department of Orthopaedics at the University of Utah and a surgeon in the Musculoskeletal Surgical Oncology Clinic within the Sarcoma Center. His University of Utah Health profile lists clinics at Huntsman Cancer Institute and Primary Children's Hospital, and specialties including soft tissue sarcoma, bone sarcoma and paediatric sarcoma surgery. He completed medical school and orthopaedic residency at the University of South Florida, holds an MS from Duke University, and completed a sarcoma surgery fellowship at the University of Utah. The profile lists American Board of Orthopaedic Surgery certification. The intake, supervision and current availability of the linked fellowship must be confirmed with the host.
Names and roles come from the cited programme source; photographs have their own cited source and do not establish an individual profile. Rosters may change.
The University of Texas MD Anderson Cancer Center Department of Orthopaedic Oncology
Houston, Texas, United States · 1-year Clinical Fellowship, with an optional second-year Advanced Musculoskeletal Oncology Fellowship (clinical, surgery and research) after completing the clinical yearView program profile →